三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
ZG005-001项目不良反应(n,%)
ZG005-001项目不良反应(n,%)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:274KB
图片尺寸:1162*855
同报告图片
/
4
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
所属报告:
泽璟制药-公司研究报告-创新进入收获期ZG006及ZG005均有望成为BIC-250714(37页).pdf
打包全文图表
相关数据
ZG005治疗宫颈癌患者的无进展生存期(IRC评估)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
表6各国不良反应监测制度对比
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
收藏
行业数据
2026-03-23
原图定位
查看详情
LBL-024联合化疗一线治疗晚期EP-NEC患者的不良反应情况
收藏
行业数据
2026-02-24
原图定位
查看详情
Amycretin(皮下注射)整体不良反应事件为轻度到中度
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
收藏
行业数据
2025-11-19
原图定位
查看详情
匹米替尼在一期临床试验中对比另外两款CSR-1R抑制剂显示出最佳的安全性,且无任何肝脏相关不良反应
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
收藏
行业数据
2025-10-10
原图定位
查看详情
Remitch中国III期桥验不良反应情
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
收藏
行业数据
2025-08-13
原图定位
查看详情
ZG005和AK104在宫颈癌的数据对比(截至20250720)
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
收藏
行业数据
2025-08-01
原图定位
查看详情
慢阻肺常用吸入式药物类型、临床应用及不良反应
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
收藏
行业数据
2025-07-30
原图定位
查看详情
ZG005:一线晚期神经内分泌癌中显示良好的有效性和安全性
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
收藏
行业数据
2025-07-15
原图定位
查看详情
ZG005:一线晚期宫颈癌中显示优异的有效性及安全性
fCDkuLTluormlrnmoYggfCBaRzAwNSDliYLph48gfCDljJbnlpfoja/niakgfCDotJ3kvJDljZXmipcgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgSeacnyB8IDIwIG1nL2tnIHwg5YyW55aXIHwg6LSd5LyQ5Y2V5oqXIHwKfCBJ5pyfIHwgMTAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAp8IElJ5pyf5omp5bGVIHwgMjAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAp8IElJ5pyf5omp5bGVIHwgMTAgbWcva2cgfCDljJbnlpcgfCDotJ3kvJDljZXmipcgfAoK6LWE5paZ5p2l5rqQ77yaQVNDT++8jOWFrOWPuOWFrOWRiu+8jOS4nOWQtOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-07-15
原图定位
查看详情
ZG005-001项目患者基线(n,%)
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
收藏
行业数据
2025-07-15
原图定位
查看详情
伏美替尼一线治疗不良反应谱(非头对头)
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
收藏
行业数据
2025-07-14
原图定位
查看详情
培莫沙肽及同类药物部分不良反应事件发生率
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
收藏
行业数据
2025-06-09
原图定位
查看详情
芦康沙妥珠、Trodelvy及Datroway的常见不良药物反应发生率
fCBBReexu+WIqyB8IOiLpuWPguaymeWuieeOrzVtZy9rZyAoTj0xODgpIHwgVHJvZGVsdnkgMTBtZy9rZyAoTj0yNTgpIHwgRGF0cm93YXkgNm1nL2tnIChOPTM2MCkgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6KGA5ray55u45YWzQUUgfCA1NCUgfCA3OCUgfCAzMCUgfAp8IOaAp+eykue7huiDnuiuoeaVsOWHj+WwkSB8IDcyJSB8IDk0JSB8IDM1JSB8Cnwg6KGA5bCP5p2/6K6h5pWw5YeP5bCRIHwgMzIlIHwgMjMlIHwgTkEgfAp8IOeZvee7huiDnuiuoeaVsOWHj+WwkSB8IDU5JSB8IDg2JSB8IDQxJSB8Cnwg5reL5be057uG6IOe6K6h5pWw5YeP5bCRIHwgMTglIHwgODglIHwgMzYlIHwKfCDogp3ohI/nm7jlhbNBRSB8IDAlIHwgTkEgfCA0LjIlIHwKfCDogr7ohI/nm7jlhbNBRSB8IDQlIHwgNTklIHwgMTElIHwKfCDohbnms7sgfCA0NCUgfCAxNyUgfCA1OSUgfAp8IOWPo+iFlOeCjiB8IDMxJSB8IDU3JSB8IDU2JSB8Cnwg5oG25b+DIHwgMjclIHwgMzMlIHwgMjQlIHwKfCDlkZXlkJAgfCA1JSB8IDM3JSB8IDM0JSB8Cnwg5L6/56eYIHwgMiUgfCAzMCUgfCAxMSUgfAp8IOWFtuS7lkFFIHwgMzUlIHwgMTIlIHwgMTclIHwKfCDnmq7nlrkgfCAzMiUgfCA0NyUgfCAyMiUgfAp8IOiEseWPkSB8IDE4JSB8IDI4JSB8IDE2JSB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jmi5vogqHkuabvvIxEYXRyb3dheeS6p+WTgeivtOaYjuS5pu+8jFRyb2RlbHZ55Lqn5ZOB6K+05piO5Lmm77yM5Lqk6ZO25Zu96ZmF44CC
收藏
行业数据
2025-05-19
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
截至 2024 年 12 月 5 日,ZG005-001 项目 I 期剂量递增阶段已完成;II 期剂量扩展阶段中,共 55 例二线及以上宫颈癌患者接受(ZG005)治疗,按 1:1 随机接受 10 mg/kg Q3W 或 20 mg/kg Q3W 治疗。①有效性方面,既往未接受过免疫检查点抑制剂治疗的二线及以上宫颈癌患者中,20 mg/kg 组(N=22)基于 IRC 评估的确认 ORR 为 40.9%,DCR为 68.2%。基于研究者评估,20 mg/kg 组 mPFS 已超过 11 个月。②安全性方面,两组整体耐受性和安全性均良好,83.6%的患者发生 TRAE,绝大多数为 1-2 级,仅 9.1%为≥3级,未发生因 TEAE 导致的死亡。
行业数据
原图定位
当前图表所属:
泽璟制药-公司研究报告-创新进入收获期ZG006及ZG005均有望成为BIC-250714(37页).pdf
自免疾病具备广阔的临床应用和市场潜力
PD-1/TIGIT药物主要进展(截至2025H1)
CD3/DLL3主要相关药物临床进展(截至2025H1)
小细胞肺癌免疫治疗专家共识(2025版)要点
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》